These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 10404429)
21. Discovery and Selection of Hepatitis B Virus-Derived T Cell Epitopes for Global Immunotherapy Based on Viral Indispensability, Conservation, and HLA-Binding Strength. de Beijer MTA; Jansen DTSL; Dou Y; van Esch WJE; Mok JY; Maas MJP; Brasser G; de Man RA; Woltman AM; Buschow SI J Virol; 2020 Mar; 94(7):. PubMed ID: 31852786 [TBL] [Abstract][Full Text] [Related]
22. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen. Penna A; Chisari FV; Bertoletti A; Missale G; Fowler P; Giuberti T; Fiaccadori F; Ferrari C J Exp Med; 1991 Dec; 174(6):1565-70. PubMed ID: 1720813 [TBL] [Abstract][Full Text] [Related]
23. Identification of cytotoxic T lymphocyte epitopes in dengue virus serotype 1. Duan Z; Guo J; Huang X; Liu H; Chen X; Jiang M; Wen J J Med Virol; 2015 Jul; 87(7):1077-89. PubMed ID: 25777343 [TBL] [Abstract][Full Text] [Related]
24. Cytotoxic T lymphocyte activity to hepatitis B virus DNA-transfected HepG2 cells in patients with chronic hepatitis B. Ito Y; Kakumu S; Yoshioka K; Wakita T; Ishikawa T; Koike K Gastroenterol Jpn; 1993 Oct; 28(5):657-65. PubMed ID: 7693538 [TBL] [Abstract][Full Text] [Related]
25. Identification of a human CD8+ T lymphocyte neo-epitope created by a ras codon 12 mutation which is restricted by the HLA-A2 allele. Bergmann-Leitner ES; Kantor JA; Shupert WL; Schlom J; Abrams SI Cell Immunol; 1998 Aug; 187(2):103-16. PubMed ID: 9732698 [TBL] [Abstract][Full Text] [Related]
26. Synthetic peptides induce a cytotoxic response against human papillomavirus type-18. Castellanos MR; Hayes RL; Maiman MA Gynecol Oncol; 2001 Jul; 82(1):77-83. PubMed ID: 11426965 [TBL] [Abstract][Full Text] [Related]
27. Molecular features of the hepatitis B virus nucleocapsid T-cell epitope 18-27: interaction with HLA and T-cell receptor. Bertoletti A; Southwood S; Chesnut R; Sette A; Falco M; Ferrara GB; Penna A; Boni C; Fiaccadori F; Ferrari C Hepatology; 1997 Oct; 26(4):1027-34. PubMed ID: 9328331 [TBL] [Abstract][Full Text] [Related]
28. Multiepitopic HLA-A*0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization. Loirat D; Lemonnier FA; Michel ML J Immunol; 2000 Oct; 165(8):4748-55. PubMed ID: 11035120 [TBL] [Abstract][Full Text] [Related]
29. Dendritic cells from chronic hepatitis B patients can induce HBV antigen-specific T cell responses. Li RB; Chen HS; Xie Y; Fei R; Cong X; Jiang D; Wang SX; Wei L; Wang Y World J Gastroenterol; 2004 Jun; 10(11):1578-82. PubMed ID: 15162529 [TBL] [Abstract][Full Text] [Related]
30. High frequency of functional anti-YMDD and -mutant cytotoxic T lymphocytes after in vitro expansion correlates with successful response to lamivudine therapy for chronic hepatitis B. Lin CL; Tsai SL; Lee TH; Chien RN; Liao SK; Liaw YF Gut; 2005 Jan; 54(1):152-61. PubMed ID: 15591521 [TBL] [Abstract][Full Text] [Related]
32. Induction in vitro of a primary human antiviral cytotoxic T cell response. Cerny A; Fowler P; Brothers MA; Houghton M; Schlicht HJ; Chisari FV Eur J Immunol; 1995 Feb; 25(2):627-30. PubMed ID: 7875224 [TBL] [Abstract][Full Text] [Related]
33. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. Battegay M; Fikes J; Di Bisceglie AM; Wentworth PA; Sette A; Celis E; Ching WM; Grakoui A; Rice CM; Kurokohchi K J Virol; 1995 Apr; 69(4):2462-70. PubMed ID: 7884894 [TBL] [Abstract][Full Text] [Related]
34. Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2. Wizel B; Houghten RA; Parker KC; Coligan JE; Church P; Gordon DM; Ballou WR; Hoffman SL J Exp Med; 1995 Nov; 182(5):1435-45. PubMed ID: 7595214 [TBL] [Abstract][Full Text] [Related]
35. An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans. Shirai M; Okada H; Nishioka M; Akatsuka T; Wychowski C; Houghten R; Pendleton CD; Feinstone SM; Berzofsky JA J Virol; 1994 May; 68(5):3334-42. PubMed ID: 7512163 [TBL] [Abstract][Full Text] [Related]
36. Natural CD8+ T-cell responses against MHC class I epitopes of the HER-2/ neu oncoprotein in patients with epithelial tumors. Sotiropoulou PA; Perez SA; Voelter V; Echner H; Missitzis I; Tsavaris NB; Papamichail M; Baxevanis CN Cancer Immunol Immunother; 2003 Dec; 52(12):771-9. PubMed ID: 13680193 [TBL] [Abstract][Full Text] [Related]
37. Use of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 region. Kurokohchi K; Akatsuka T; Pendleton CD; Takamizawa A; Nishioka M; Battegay M; Feinstone SM; Berzofsky JA J Virol; 1996 Jan; 70(1):232-40. PubMed ID: 8523531 [TBL] [Abstract][Full Text] [Related]
38. [Identification of a novel HLA-A2-restrictive CTL epitope of an ovary cancer-associated antigen OVA66]. Jin S; Wang Y; Wang SJ; Zhang HZ; Li MX; Chen Y; Ge HL Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Mar; 21(2):233-6, 242. PubMed ID: 15766414 [TBL] [Abstract][Full Text] [Related]
39. Characterization of an immunologically conserved epitope from hepatitis C virus E2 glycoprotein recognized by HLA-A2 restricted cytotoxic T lymphocytes. Sarobe P; Huarte E; Lasarte JJ; López-Díaz de Cerio A; García N; Borrás-Cuesta F; Prieto J J Hepatol; 2001 Feb; 34(2):321-9. PubMed ID: 11281563 [TBL] [Abstract][Full Text] [Related]
40. Hepatitis B virus core antigen epitopes presented by HLA-A2 single-chain trimers induce functional epitope-specific CD8+ T-cell responses in HLA-A2.1/Kb transgenic mice. Zhang Y; Li S; Shan M; Pan X; Zhuang K; He L; Gould K; Tien P Immunology; 2007 May; 121(1):105-12. PubMed ID: 17244158 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]